Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acquired Antithrombin III Deficiency”

3 trials

Showing 3 of 3 results

Large-scale testing (Phase 3)Looking for participantsNCT06096116
What this trial is testing

Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass

Who this might be right for
Acquired Antithrombin Deficiency
Octapharma 120
Testing effectiveness (Phase 2)Study completedNCT00823082
What this trial is testing

Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass

Who this might be right for
Acquired Antithrombin III DeficiencyCoronary Artery Bypass
Instituto Grifols, S.A. 200
Post-approval studies (Phase 4)Ended earlyNCT01547728
What this trial is testing

Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery

Who this might be right for
Thrombophilia Due to Acquired Antithrombin III Deficiency
Mayo Clinic 42

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation